Olanzapine response in schizophrenic subjects with neuroleptic resistant disorganization

被引:1
|
作者
Richardson, C [1 ]
Conley, R [1 ]
机构
[1] UNIV MARYLAND,MARYLAND PSYCHIAT RES CTR,CATONSVILLE,MD 21228
关键词
D O I
10.1016/S0920-9964(97)82546-7
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:191 / 191
页数:1
相关论文
共 50 条
  • [1] CLOZAPINE RESPONSE IN SCHIZOPHRENIC SUBJECTS WITH NEUROLETPIC RESISTANT DISORGANIZATION
    RICHARDSON, C
    CONLEY, R
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 162 - 163
  • [2] THERAPEUTIC EFFICACY OF CHOLECYSTOKININ IN NEUROLEPTIC-RESISTANT SCHIZOPHRENIC SUBJECTS
    NAIR, NPV
    BLOOM, DM
    NESTOROS, JN
    SCHWARTZ, G
    PSYCHOPHARMACOLOGY BULLETIN, 1983, 19 (01) : 134 - 136
  • [3] Olanzapine:: keep an eye on this neuroleptic -: Response
    Toussaint, B
    CANADIAN FAMILY PHYSICIAN, 2000, 46 : 1569 - 1569
  • [4] TREATMENT OF NEUROLEPTIC-RESISTANT SCHIZOPHRENIC RELAPSE
    KINON, BJ
    KANE, JM
    JOHNS, C
    PEROVICH, R
    ISMI, M
    KOREEN, A
    WEIDEN, P
    PSYCHOPHARMACOLOGY BULLETIN, 1993, 29 (02) : 309 - 314
  • [5] Social cognition in schizophrenic and bipolar subjects treated with olanzapine
    Mazza, M
    Pollice, R
    Tozzini, C
    De Risio, A
    Pomero, P
    Marola, V
    Roncone, R
    Casacchia, M
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 175 - 175
  • [6] Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response
    Conley, RR
    Tamminga, CA
    Kelly, DL
    Richardson, CM
    BIOLOGICAL PSYCHIATRY, 1999, 46 (01) : 73 - 77
  • [7] Intermittent neuroleptic treatment of therapy-resistant schizophrenic psychoses
    Campo, JA
    Nijman, H
    Merckelbach, H
    EUROPEAN JOURNAL OF PSYCHIATRY, 1997, 11 (02): : 69 - 71
  • [8] Combination of amisulpride and olanzapine in treatment-resistant schizophrenic psychoses
    Zink, M
    Henn, FA
    Thome, J
    EUROPEAN PSYCHIATRY, 2004, 19 (01) : 56 - 58
  • [9] Response and remission in schizophrenic subjects
    Zimmermann, J.
    Wolter, A.
    Krischke, N. R.
    Preuss, U. W.
    Wobrock, T.
    Falkai, P.
    NERVENARZT, 2011, 82 (11): : 1440 - 1448
  • [10] NEUROLEPTIC TREATMENT IS AN UNLIKELY CAUSE OF ELEVATED DOPAMINE IN THALAMUS OF SCHIZOPHRENIC SUBJECTS
    OKE, AF
    PUTZ, C
    ADAMS, RN
    BIRD, ED
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1992, 45 (04) : 203 - 208